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ABSTRACT
Objectives: The aims of the study were to understand how education relates to contraceptive
choice and how sexual function can vary in relation to the use of a contraceptive method.
Methods: We surveyed female medical students and women attending a family planning service
(FPS) in Italy. Participants completed an online questionnaire which asked for information on socio-
demographics, lifestyle, sexuality and contraceptive use and also included items of the Female
Sexual Function Index (FSFI).
Results: The questionnaire was completed by 413 women (362 students and 51 women attending
the FPS) between the ages of 18 and 30 years. FSFI scores revealed a lower risk of sexual dysfunc-
tion among women in the control group who did not use oral hormonal contraception. The differ-
ences in FSFI total scores between the two study groups, when subdivided by the primary
contraceptive method used, was statistically significant (p< 0.005). Women using the vaginal ring
had the lowest risk of sexual dysfunction, compared with all other women, and had a positive sex-
ual function profile. In particular, the highest FSFI domain scores were lubrication, orgasm and sat-
isfaction, also among the control group. Expensive contraception, such as long-acting reversible
contraception, was not preferred by this young population, even though such methods are more
contemporary and manageable. Compared with controls, students had lower compliance with
contraception and a negative attitude towards voluntary termination of pregnancy.
Conclusion: Despite their scientific knowledge, Italian female medical students were found to
need sexual and contraceptive assistance. A woman’s sexual function responds to her awareness
of her body and varies in relation to how she is guided in her contraceptive choice. Contraceptive
counselling is an excellent means to improve female sexuality.
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Introduction
Contraceptive use has changed considerably over time. In
recent decades it has become more widespread, yet it is still
affected by numerous sociocultural variables. Nationality,
ethnicity, religion, age, parity, educational level, relationship
status, economic circumstances and pregnancy intentions all
have a bearing on determining the contraceptive method
and use; furthermore, satisfaction with the method affects
female sexuality [1–5]. For example, the use of hormonal
contraception has been reported to be associated with
altered sexual function in female medical students [6,7].
Poor education results in incorrect or non-use of contra-
ception, leading to unwanted pregnancy. Socioeconomic
factors are the most significant variables related to contra-
ceptive failure [8]. By contrast, educational interventions
can help to increase awareness of contraceptive methods,
allowing people to make informed decisions and use
contraceptive methods effectively [9]. To understand how
educational level relates to contraceptive choice and how
sexual function can vary in relation to the use of a contra-
ceptive method, we surveyed two Italian populations that
differed in terms of education: female medical students
and healthy women attending a family planning service
(FPS) for a routine appointment. We hypothesised that the
university cohort, considered better educated and aware of
their bodies thanks to their field of study, would have a
lower risk of sexual dysfunction.
Methods
Study population and research ethics
Participants were recruited from two settings. Female med-
ical students were recruited through the online social net-
work of faculty and student associations of 34 Italian
universities (universities of Salerno, Bari Aldo Moro,
Bologna, Brescia, Cagliari, Catanzaro Magna Grecia,
Chieti–Pescara Gabriele D’Annunzio, Ferrara, Firenze,
Foggia, Genova, L’Aquila, Messina, Milano, Milano Bicocca,
Milano Libera Universita Vita Salute S. Raffaele, Modena e
Reggio-Emilia, Napoli Federico II, Napoli Luigi Vanvitelli,
Padova, Palermo, Parma, Pavia, Perugia, Pisa, Roma
Universita Cattolica del Sacro Cuore, Roma La Sapienza,
Roma Tor Vergata, Sassari, Siena, Torino, Trieste, Udine,
Varese–Como Insubria). The only inclusion criterion was the
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self-declared status of being a female medical student.
Students over 30 years of age were excluded because the
study focused on women of typical student age. For com-
parison, we recruited healthy women attending the FPS of
our health district in Salerno, Italy, by direct invitation dur-
ing outpatient visits. Exclusion criteria were the following:
having received medical training, age over 30 years and
previous pregnancy.
The two cohorts differed not only in terms of medical
studies but also in their degree of schooling. Our aim
was to highlight the possible differences in contraceptive
choice and sexuality between young women who were
well or less well educated. While all female students have
a high school diploma and a small percentage (1–2%)
already have a degree in another discipline (pharmacy,
biotechnology, science or foreign languages), women
attending the FPS are likely to have a lower level of edu-
cation: about half (52%) had a high school diploma, while
the remaining 48% had stopped their studies at the age
of 14.
A sample size was based on feasibility and not on for-
mal calculation. We expected to be able to enrol 350 stu-
dents and 50 controls. With this sample size, we would be
able to use a two-sided Mann–Whitney U test with 80%
power and a 5% alpha error, a median score of 27 points
on the Female Sexual Function Index (FSFI) with a standard
deviation (SD) of 6 and a difference in score of 2.5.
However, analyses were only planned as exploratory.
Interested participants were given details of the study,
including a guarantee of anonymity and complete confi-
dentiality. The study protocol was approval by the ethics
committee of the Scuola Medica Salernitana, University of
Salerno (protocol 98, 22 December 2012).
Online questionnaire
Study data were collected and managed using REDCap
(Research Electronic Data Capture) electronic data capture
tools hosted by the University of Salerno [10]. REDCap is a
secure, web-based application designed to support data
capture for research studies, providing an intuitive interface
for validated data entry, audit trails for tracking data
manipulation and export procedures, automated export
procedures for seamless data downloads to common statis-
tical packages, and procedures for importing data from
external sources.
The study electronic case report form (eCRF), adminis-
tered according to good practice in conducting and report-
ing surveys [11], was placed online in January 2017 and
closed after 6 months. Medical students accessed the eCRF
via a weblink, while control participants completed it on a
computer in the clinic waiting room. The eCRF had two
parts. The first consisted of 17 general questions about age,
height and weight (for calculation of body mass index
[BMI]), age at first sexual intercourse (<15 years, 15–18
years, 18–25 years and >25 years), having a steady relation-
ship in the previous 6 months, lifestyle factors including
smoking (yes/no), alcohol consumption (never, occasionally,
daily), level of fitness (very fit, in good shape, average, not
very fit, in poor shape), type of contraception used (pill,
vaginal ring, subcutaneous implant, patch, intrauterine
device [IUD], condom, diaphragm, coitus interruptus, natural
family planning/abstinence), current and past use of hormo-
nal contraception (including pill composition), features that
guided the choice of contraception, use of emergency
contraception (never, once, more than once) and history of
voluntary termination of pregnancy. Students were also
asked to name their university, and controls to state the
number of years they attended school.
The second part contained the validated Italian trans-
lation of the FSFI [12,13], a 19-item, multidimensional
self-reporting tool that evaluates six key dimensions of
female sexual function: desire, arousal, lubrication,
orgasm, satisfaction and pain, with regard to participants’
sexual experiences during the previous 4 weeks. A total
score <26.55 identifies respondents at risk of sexual dys-
function [14]. The FSFI is a validated questionnaire that
has been developed for the specific purpose of assessing
the fundamental domains of sexual function (i.e., sexual
arousal, desire, lubrication, orgasm, satisfaction, pain) in
clinical trials over a specific period of time. It can be
therefore used as a tool for the measure of female sexual
function [12–14].
Statistical analysis
Descriptive statistics were produced for sociodemographic,
clinical and laboratory characteristics. Mean and SD values
are presented for normally distributed variables, median
and interquartile range (IQR) for non-normally distributed
variables, and number and percentage for categorical varia-
bles. Groups were compared using parametric or non-para-
metric tests, according to the data distribution, for
continuous variables, and Pearson’s v2 test (Fisher exact
test where appropriate) for categorical variables.
Correlation between continuous variables was assessed
using Pearson’s or Spearman’s coefficient, according to the
data distribution.
In all cases, two-tailed tests were used. The significance
level was set at 5%. The main comparison was between
the two groups (students versus controls). Interaction
between study group and type of contraception by FSFI
domain was analysed by subgroups, defined by the pri-
mary method of contraception used: non-hormonal (con-
doms), oral hormonal, non-oral hormonal (vaginal ring) or
no medical contraception (abstinence or coitus interruptus).
Median regression was used to assess potential determi-
nants of total FSFI score. All statistical analyses used R soft-
ware, version 3.0.0 (R Foundation for Statistical Computing,
Vienna, Austria) [15].
Results
Questionnaires were completed by 432 women (381 med-
ical students and 51 controls). However, 19 students were
>30 years old and thus excluded. Therefore, 413 individu-
als were analysed (362 students and 51 controls) (Table 1).
Students were slightly older and were less likely to smoke,
have been in a stable relationship in the previous 6 months
or have a history of voluntary pregnancy termination.
Hormonal contraception was used by 111 (30.7%) stu-
dents and 24 (47.1%) controls (p¼ 0.025). Among those
currently using hormonal contraception, 35 (31.5%) stu-
dents and 14 (58.3%) controls had a history of also using
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emergency contraception (p¼ 0.01). The most frequently
used contraceptive methods in students and controls were,
respectively: condoms (52.8% versus 37.2%), contraceptive
pills (27.3% versus 31.4%), coitus interruptus (10.7% versus
11.8%) and the vaginal ring (3.3% versus 15.7%) (p¼ 0.01)
(Figure 1). These four methods accounted for 94% of
contraceptive users in each group. No participant used a
subcutaneous implant, IUD or diaphragm; one control par-
ticipant used a patch (60 mg/24 h gestodene and 13 mg/
24 h ethinylestradiol [EE]). Of student pill users, 82% took
pills containing 20 or 30 mg EE, the remainder used pills
containing natural estrogens (i.e., estradiol valerate) or pills
containing 15 or 35 mg EE (Figure 2). Conversely, 87.5% of
pill users in the control group reported using pills contain-
ing 20 or 30 mg EE, with the remainder taking pills contain-
ing natural estrogens.
A history of voluntary induced abortion was recorded in
11 (3.0%) students and five (9.8%) controls.
Table 1. Sociodemographic and clinical characteristics of the study groups.
Characteristic Students (n¼ 362) Controls (n¼ 51) p-value
Age, in years, mean (SD) 22.8 (2.4) 20.4 (3.4) <0.001
BMI, in kg/m2, mean (SD) 21.6 (3.0) 22.4 (4.8) 0.10
Smoking habit, n (%) 88 (24.3) 20 (39.2) 0.028
Alcohol consumption, n (%)
Never 41 (11.3) 14 (27.5) 0.009
Occasionally 315 (87.0) 37 (72.5)
Daily 6 (1.7) 0 (0)
Level of fitness, n (%)
Very fit 6 (1.7) 3 (5.9) 0.14
In good shape 75 (20.7) 8 (15.7)
Average 135 (37.3) 15 (29.4)
Not very fit 131 (36.2) 21 (41.2)
In poor shape 15 (4.1) 4 (7.8)
Age at first sexual intercourse, in years, n (%)
<15 31 (8.6) 6 (11.8) 0.07
15–18 200 (55.2) 36 (70.6)
19–25 138 (38.1) 9 (17.6)
>25 7 (1.9) 0 (0)
No response 3 (0.8) 0 (0)
Steady relationship in past 6 months, n (%) 280 (77.3) 48 (94.1) 0.005
Current use of hormonal contraception, n (%) 111 (30.7) 24 (47.1) 0.025
Emergency contraception, n (%)
Never 242 (66.9) 29 (56.9) 0.33
Once 81 (22.4) 17 (33.3)
More than once 36 (9.9) 5 (9.8)
No response 3 (0.8) 0 (0)
History of voluntary pregnancy termination, n (%) 11 (3.0) 5 (9.8) 0.036
Contraception after voluntary pregnancy termination, n (%)
No contraception/non-hormonal contraception 4 (36.4) 0 (0)
Oral hormonal contraception/non-oral hormonal contraception 7 (63.7) 5 (100)
Figure 1. Main contraceptive method used, by the study group.
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Sexual function
The difference in FSFI total scores between the two study
groups, when subdivided by the primary contraceptive
method used, was statistically significant (p< 0.005).
Median (IQR) FSFI total scores were 28.6 (24.6–31.7) for stu-
dents and 28.2 (24.9–29.9) for controls (p¼ 0.29) (Table 2).
The FSFI identified potential sexual dysfunction in 124
(34.3%) students and 14 (27.5%) controls (p¼ 0.34).
The groups had similar scores in all domains except
arousal, where students had a higher score (p¼ 0.027)
(Table 2). In the subgroup using oral hormonal contracep-
tion, students and controls had different scores overall in
the arousal and lubrication domains. All domain scores were
slightly higher for students. Scores were higher in non-oral
hormonal contraception users than in other subgroups,
which was particularly significant in the desired domain
(p¼ 0.052). Table 2 summarises the analysis performed to
assess the influence of various types of contraceptives. In
univariate analysis, the variables associated with FSFI total
score were having a stable partner (which increased the
score) and later age at first intercourse and use of coitus
interruptus (which lowered the score) (Table 3).
The results with regard to the history of voluntary ter-
mination of pregnancy are presented in Table 4. Total FSFI
scores in these subgroups were slightly lower than those in
Table 2; pain and satisfaction appeared inversely correlated
in students versus controls.
Discussion
Findings and interpretation
We found no noticeable differences in epidemiological
characteristics between the students and controls, except
for age at first sexual intercourse, which was younger in
controls than in students (<15 years old; 11.8% versus
8.6%, respectively); being in a stable relationship, which
was less common for students than for controls (77.3% ver-
sus 94.1%, respectively); and the percentage of respond-
ents who used hormonal contraception and reported
having used emergency contraception (58.3% of controls
versus 31.5% of students). Our initial hypothesis that uni-
versity students would have a lower risk of sexual dysfunc-
tion appears not to have been completely valid.
Hormonal contraception was widely used by both groups.
The pill (by 27.3% of students and 31.4% of controls) and
vaginal ring (by 3.3% and 15.7%, respectively) were common.
The results regarding the vaginal ring are interesting, show-
ing higher median (IQR) values in both groups: students 29.2
(23.4–30.8) versus controls 29.1 (27.4–30.4).
Condoms were the most common contraceptive method
in both groups, owing to availability, low cost and protec-
tion from infection. The acceptability of condoms in terms
of sexual experience is controversial. According to some
studies, they can negatively interfere with sexual pleasure
and arousal, can reduce vaginal lubrication and lead to dis-
comfort and pain [16–18]. Other studies, however, found
no particular alteration and indeed attributed various bene-
fits to them: in the USA, no association was found between
reduced sexual function and condom use [19]; in Europe,
users reported longer sexual intercourse and personal feel-
ings of cleanliness and sexual hygiene [20]. Our results
might be explained by the higher percentage of controls
having a stable relationship compared with the students
(94.1% versus 77.3%).
Condom users had FSFI scores that substantially over-
lapped with those practising coitus interruptus. A recent
study of undergraduates at the University of Seville found
that knowledge about contraception was lower among
young people using coitus interruptus or no contraception
[21]. In our study, coitus interruptus was equally used by
14% of students and controls. The students in the current
study certainly knew about the lack of safety and inconsist-
ency of this method, with a consequent negative impact on
sexual function. In fact, the students who used no contracep-
tion had a lower total FSFI scores compared with those who
used oral hormonal contraception (median [IQR]: no contra-
ception 28.3 [24.2–32.0] versus oral hormonal contraception
29.1 [25.1–32.1]) or the vaginal ring (29.2 [23.4–30.8]).
Moreover, these values were also lower than those of the
non-contraceptive users in the control group (29.3
[24.3–30.5]). On the other hand, the control group had higher
FSFI values among non-contraceptive users than among oral
Figure 2. Type of oral hormonal contraception used, by the study group.
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hormonal contraceptive users (29.3 [24.3–30.5] versus 27.3
[20.7–28.7], respectively). It would be interesting to investi-
gate why students used coitus interruptus even though they
knew it was ineffective.
Another important issue is the sexual function of young
women after voluntary termination of pregnancy in the
first trimester (<90 days, in accordance with Italian law no.
194/1978). A decline in sexual function after abortion has
been found in different cultures [22,23], owing to possible
psychological trauma and worry about another unwanted
pregnancy [24]. In our study, sexual function after abortion
was lower in students than in controls; 100% of controls
were using hormonal contraception (oral or non-oral),
whereas only 63% of students were using oral hormonal
contraception and the remaining 37% non-oral hormonal
contraception (Table 1).
Differences and similarities in relation to other studies
In 2008, Shindel et al. [25] found that 63% of female med-
ical students were at risk of sexual dysfunction. In 2010,
Wallwiener et al. [7] found a high percentage of sexual
dysfunction in this population. We also analysed sexual
function among a population of medical students through
questionnaires and evaluation of the FSFI. In our study,
data were collected through the REDCap platform and stu-
dents were compared with a demographically matched
cohort with a different level of schooling.
Strengths and weaknesses
The questionnaire explored different areas of lifestyle and
factors potentially associated with sexual function. Using a
simple method of data collection, the questionnaire offered
access to a large amount of data that may be useful for
pharmacologists in understanding how to direct scientific
research and for clinicians in contraceptive counselling.
Although our pilot study consisted of a small sample, it is,
as far as we know, the first in Italy to evaluate contracep-
tive choice and sexual function in this particular type of
population. Although there were not many epidemiological
differences between the two cohorts, they were
Table 2. FSFI domain scores by type of contraception.
Students Controls
Contraception and FSFI domain n (%) Median IQR n (%) Median IQR p-value
All contraception 362 (100) 51 (100)
Total 28.6 24.6–31.7 28.2 24.9–29.9 0.295
Desire 3.6 3.6–4.8 3.6 2.4–3.6 0.753
Arousal 4.8 3.9–5.4 4.5 3.9–5.1 0.027
Lubrication 5.7 4.5–6.0 5.4 4.2–6.0 0.114
Orgasm 4.8 3.2–5.6 4.6 4.0–5.2 0.960
Satisfaction 4.8 4.0–5.6 5.2 4.8–5.6 0.113
Pain 4.8 3.6–6.0 4.8 3.6–6.0 0.570
Non-hormonal contraception 190 (52.5) 19 (37.3)
Total 28.2 23.3–30.8 28.2 26.9–30.4 0.778
Desire 3.6 3.6–4.2 3.6 3.6–4.8 0.396
Arousal 4.8 3.6–5.4 4.5 3.9–5.1 0.250
Lubrication 5.4 4.5–6 5.7 4.8–6 0.462
Orgasm 4.8 2.8–5.6 4.8 3.6–5.2 0.716
Satisfaction 4.8 3.6–5.6 4.8 4.4–5.6 0.400
Pain 4.8 3.6–6 5.2 4.0–6.0 0.418
Oral hormonal contraception 99 (27.3) 16 (31.4)
Total 29.1 25.1–32.1 27.3 20.7–28.7 0.016
Desire 3.6 3.6–4.8 3.6 3.3–3.6 0.069
Arousal 5.1 3.9–5.7 4.3 3.1–4.5 0.013
Lubrication 5.7 4.8–6.0 4.0 3.3–5.2 <0.001
Orgasm 4.8 3.6–5.6 4.4 3.4–5.2 0.238
Satisfaction 5.2 4.4–5.6 5.0 4.8–5.6 0.816
Pain 5.2 3.6–6 4.0 3.2–5.8 0.284
Non-oral hormonal contraception 12 (3.3) 8 (15.7)
Total 29.2 23.4–30.8 29.1 27.4–30.4 0.908
Desire 4.2 3.6–4.8 3.6 3.6–3.6 0.052
Arousal 4.9 4.0–5.1 4.6 4.2–5.2 0.938
Lubrication 5.4 4.0–6.0 5.5 5.1–6.0 0.692
Orgasm 4.8 4.0–5.4 5.6 5.2–5.6 0.108
Satisfaction 4.8 4.6–5.4 5.6 5-5–6.0 0.250
Pain 4.4 2.8–6.0 4.8 3.0–5.4 0.815
No contraception 51 (14.1) 7 (13.7)
Total 28.3 24.2–32.0 29.3 24.3–30.5 0.768
Desire 3.6 3.0–4.2 4.2 3.6–4.8 0.102
Arousal 4.8 3.0–5.7 4.2 3.9–5.1 0.636
Lubrication 5.7 3.9–6.0 4.8 4.2–5.4 0.260
Orgasm 4.8 2.8–5.6 4.4 4.0–5.2 0.990
Satisfaction 5.2 3.2–5.6 5.6 4.8–6.0 0.230
Pain 5.6 3.6–6.0 4.4 3.2–6.0 0.426
Other/not known 10 (2.8) 1 (2.0)
Total 28.7 24.9–32.1 30.0 30.0–30.0 1.0
Desire 3.6 3.6–4.8 4.2 4.2–4.2 0.617
Arousal 5.2 4.5–5.7 5.4 5.4–5.4 0.749
Lubrication 5.8 5.4–6.0 6.0 6.0–6.0 0.387
Orgasm 5.0 3.2–6.0 5.2 5.2–5.2 0.873
Satisfaction 5.0 4.4–5.2 5.2 5.2–5.2 0.625
Pain 4.8 2.0–5.2 4.0 4.0–4.0 0.521
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substantially different from an educational point of view
and in terms of body awareness.
Relevance of the findings: implications for clinicians
and policy-makers/health care providers
The evolution of hormonal contraception not only brings
improvements in many symptoms but also the emergence
of new issues (e.g., dyspareunia), particularly with regard to
Table 3. Analysis of the participants’ data.
Variable Coefficient Confidence interval p-value
Study group
Students Ref.
Controls 0.400 2.322, 1.522 0.683
Age, for each year 0.213 0.015, 0.44 0.067
BMI, for each point 0.072 0.13, 0.274 0.484
Weight, for each kg 0.018 0.044, 0.079 0.572
Height, for each cm 3.636 12.907, 5.634 0.442
Age at first intercourse, years
<15 Ref.
15–18 0.200 1.945, 2.345 0.855
19–25 0.300 1.929, 2.529 0.792
>25 23.200 28.708, 17.692 0.000
Stable partner
No Ref.
Yes 4.000 2.382, 5.618 0.000
Smoking
No Ref.
Yes 1.300 2.714, 0.114 0.072
Alcohol intake
Never Ref.
Occasionally 1.700 0.15, 3.55 0.072
Daily 0.300 5.012, 5.612 0.912
Length of education, years
8 Ref.
13 1.000 2.991, 4.991 0.623
>16 (university degree) 2.200 4.325, 8.725 0.509
University student 1.700 1.557, 4.957 0.306
Physical activity
Very fit Ref.
In good shape 0.600 3.454, 4.654 0.772
Average 0.900 3.063, 4.863 0.656
Not very fit 0.100 4.052, 3.852 0.960
In poor shape 1.300 6.001, 3.401 0.588
Contraception
Oral hormonal Ref.
Vaginal ring 0.300 2.771, 3.371 0.848
Transdermal patch 3.300 9.133, 15.733 0.603
Condoms 0.400 1.866, 1.066 0.593
Coitus interruptus 1.100 1.224, 3.424 0.354
Abstinence/natural family planning 7.900 11.409, 4.391 0.000
Other/no response 1.400 2.511, 5.311 0.483
Hormonal contraception
No Ref.
Yes 0.400 0.809, 1.609 0.517
Type of contraception
Non-hormonal Ref.
Oral hormonal 0.400 1.055, 1.855 0.590
Non-oral hormonal 0.700 2.183, 3.583 0.634
No contraception 0.100 1.816, 2.016 0.919
Other/not known 1.800 2.006, 5.606 0.354
Current duration of use of contraception, months
<3 Ref.
3–6 0.600 3.916, 2.716 0.723
6–12 1.800 4.717, 1.117 0.226
>12 0.900 3.163, 1.363 0.436
Emergency contraception
Never Ref.
Once 0.500 2.019, 1.019 0.519
More than once 0.500 2.624, 1.624 0.645
Ever used emergency contraception
No Ref.
Yes 0.500 1.815, 0.815 0.456
History of voluntary pregnancy termination
No Ref.
Yes 1.200 4.257, 1.857 0.442
p< 0.05.
Table 4. FSFI domain scores after voluntary-induced abortion.
Students (n¼ 11, 3.0%) Controls (n¼ 5, 9.8%)
FSFI domain Median IQR Median IQR p-value
Total 27.4 21.4–30.7 27.5 27.3–29.1 0.955
Desire 3.6 3.0–4.8 3.6 3.6–3.6 1.0
Arousal 5.1 3.6–5.4 4.5 4.5–4.5 0.730
Lubrication 5.7 4.8–6.0 4.8 3.9–5.1 0.243
Orgasm 4.8 1.2–5.6 4.4 4.4–5.2 0.689
Satisfaction 4.8 3.2–5.6 5.1 4.8–5.6 0.327
Pain 5.6 3.2–6.0 4.8 3.2–5.6 0.452
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low-dose combined oral contraceptives [26]. Non-oral
administration of combined hormones seems to be one of
the best contraceptive choices, allowing the gynaecologist
to improve metabolic and psycho-relational patterns
[1,27,28]. In our study, women using the vaginal ring
reported overall positive results in sexual function, perhaps
because of an increase in sexual fantasy for them and their
partners, as previously suggested [2].
After surgical or medical pregnancy termination all
women should be guided in choosing hormonal contracep-
tion. Contraceptive counselling is the basis of post-abortion
care: it is the right time to give contraceptive advice, when
women often specifically ask for information about contra-
ception, especially young women who are anxious to
resume their sexual life [29]. After abortion, women adhere
better to hormone therapy and attend clinical examinations
more consistently compared with those seeking preventive
hormonal contraception [30]. Despite this, in our study, the
students had a lower use of hormonal contraception com-
pared with the controls (63.7% versus 100%; Table 1).
Furthermore, despite appreciating the ‘forgettable’ nature
and long duration of use of long-acting reversible contra-
ception, young women who have undergone a voluntary
termination of pregnancy have been found to prefer not to
use contraceptives such as IUDs and subcutaneous
implants, probably because of the high initial costs [31].
Post-abortion contraceptive counselling not only improves
contraceptive use but also prevents any decline in sexual
function. From an economic viewpoint, most participants
preferred cheaper methods such as condoms, the vaginal
ring (with higher mean FSFI scores among the student
group) and the pill, the latter being the contraceptive of
choice with the best sexual function profile in students.
Beyond contraception, being in a steady relationship, hav-
ing better physical fitness and greater self-acceptance were
better represented among the control group and were
associated with higher FSFI total scores (implying a lower
risk of sexual dysfunction).
Unanswered questions and future research
It would be interesting to understand why female students
use contraceptive methods that are notoriously ineffective
and why their sexual life seems less satisfactory than that
of their peers. Another element that could be explored is
the emotional and psychological aspects of FPS visits with
respect to women who do not use these services (such as
the students in our study). Given the complexity of the
topic, many elements require further investigation.
Awareness campaigns are needed so that all young
women (regardless of schooling) can fully understand
issues about contraception. Improvement in reproductive
health is important. Special training programmes for med-
ical undergraduates could encourage direct relationships
with different professional figures such as gynaecologists,
urologists, sexologists, midwives, infectious disease special-
ists and psychologists.
Conclusion
Awareness of one’s own body and knowledge of the
physiological mechanisms that underlie female fertility are
important but not sufficient to improve sexuality. The con-
trol group used more reliable contraception and seemed to
enjoy their sexuality more, even after situations such as
abortion, possibly because they were constantly reassured
and followed by the FPS team. On the other hand, the stu-
dents made less effective contraceptive choices, with a
consequently negative impact on sexual function, despite
being aware of the risks. The two groups shared in com-
mon a preference for cheap and easy-to-use contraception.
The vaginal ring was associated with better sexual function.
Future studies should be carried out in larger samples,
comparing medical students with a population with the
same level of schooling, or evaluating the same popula-
tions after carrying out awareness campaigns.
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